Morgan Stanley’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58B Buy
12,331,553
+839,870
+7% +$105M 0.09% 190
2025
Q4
$1.4B Buy
11,491,683
+882,718
+8% +$101M 0.08% 212
2025
Q3
$1.06B Sell
10,608,965
-807,651
-7% -$72.7M 0.06% 267
2025
Q2
$947M Buy
11,416,616
+504,492
+5% +$40.2M 0.06% 284
2025
Q1
$885M Buy
10,912,124
+742,059
+7% +$66.3M 0.06% 291
2024
Q4
$916M Buy
10,170,065
+2,150,123
+27% +$208M 0.06% 276
2024
Q3
$792M Buy
8,019,942
+1,606,842
+25% +$158M 0.06% 310
2024
Q2
$595M Sell
6,413,100
-891,403
-12% -$79.9M 0.05% 377
2024
Q1
$693M Sell
7,304,503
-3,431,283
-32% -$318M 0.06% 318
2023
Q4
$959M Buy
10,735,786
+3,376,851
+46% +$251M 0.04% 416
2023
Q3
$537M Sell
7,358,935
-259,735
-3% -$20.7M 0.05% 341
2023
Q2
$634M Sell
7,618,670
-488,606
-6% -$40.9M 0.06% 294
2023
Q1
$618M Buy
8,107,276
+704,967
+10% +$58.5M 0.07% 287
2022
Q4
$614M Sell
7,402,309
-1,311,852
-15% -$106M 0.07% 293
2022
Q3
$691M Sell
8,714,161
-737,929
-8% -$62.2M 0.09% 209
2022
Q2
$702M Sell
9,452,090
-516,120
-5% -$38.7M 0.09% 216
2022
Q1
$896M Buy
9,968,210
+6,908,170
+226% +$638M 0.12% 177
2021
Q4
$343M Sell
3,060,040
-256,088
-8% -$30.9M 0.04% 389
2021
Q3
$417M Sell
3,316,128
-648,449
-16% -$83.5M 0.06% 307
2021
Q2
$537M Sell
3,964,577
-9,386,009
-70% -$1.23B 0.07% 252
2021
Q1
$1.81B Sell
13,350,586
-2,074,069
-13% -$311M 0.27% 84
2020
Q4
$2.17B Buy
15,424,655
+3,939,244
+34% +$505M 0.34% 63
2020
Q3
$1.28B Buy
11,485,411
+3,942,285
+52% +$442M 0.25% 90
2020
Q2
$844M Sell
7,543,126
-1,459,776
-16% -$144M 0.19% 125
2020
Q1
$697M Buy
9,002,902
+1,387,956
+18% +$123M 0.19% 124
2019
Q4
$724M Sell
7,614,946
-214,985
-3% -$18.6M 0.17% 127
2019
Q3
$597M Sell
7,829,931
-1,474,931
-16% -$123M 0.16% 136
2019
Q2
$816M Sell
9,304,862
-2,667,677
-22% -$228M 0.22% 103
2019
Q1
$1.08B Buy
11,972,539
+4,360,962
+57% +$371M 0.31% 77
2018
Q4
$546M Buy
7,611,577
+351,214
+5% +$28.3M 0.16% 135
2018
Q3
$696M Sell
7,260,363
-2,308,476
-24% -$224M 0.17% 123
2018
Q2
$911M Buy
9,568,839
+1,840,100
+24% +$169M 0.25% 88
2018
Q1
$678M Buy
7,728,739
+2,073,979
+37% +$189M 0.19% 107
2017
Q4
$480M Sell
5,654,760
-128,346
-2% -$10.8M 0.13% 159
2017
Q3
$501M Sell
5,783,106
-489,921
-8% -$39.3M 0.15% 148
2017
Q2
$484M Buy
6,273,027
+877,519
+16% +$62.2M 0.15% 162
2017
Q1
$374M Buy
5,395,508
+808,532
+18% +$54.3M 0.12% 189
2016
Q4
$272M Sell
4,586,976
-47,284
-1% -$2.92M 0.09% 248
2016
Q3
$307M Buy
4,634,260
+587,307
+15% +$36.3M 0.1% 207
2016
Q2
$219M Sell
4,046,953
-2,646,020
-40% -$145M 0.08% 280
2016
Q1
$346M Sell
6,692,973
-5,924,549
-47% -$308M 0.13% 173
2015
Q4
$886M Buy
12,617,522
+629,971
+5% +$43M 0.32% 57
2015
Q3
$746M Buy
11,987,551
+5,287,126
+79% +$417M 0.28% 67
2015
Q2
$563M Buy
6,700,425
+1,611,954
+32% +$125M 0.2% 118
2015
Q1
$382M Buy
5,088,471
+1,530,783
+43% +$107M 0.14% 169
2014
Q4
$221M Sell
3,557,688
-693,654
-16% -$39.5M 0.08% 275
2014
Q3
$221M Sell
4,251,342
-42,930
-1% -$2.19M 0.09% 263
2014
Q2
$220M Buy
4,294,272
+209,916
+5% +$9.46M 0.09% 261
2014
Q1
$194M Buy
4,084,356
+37,719
+0.9% +$1.93M 0.08% 280
2013
Q4
$176M Buy
4,046,637
+2,315,943
+134% +$95.9M 0.07% 296
2013
Q3
$74.5M Buy
1,730,694
+100,017
+6% +$4.05M 0.04% 510
2013
Q2
$56.7M Buy
+1,630,677
New +$57.3M 0.03% 600

Other funds holding XBI